mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.7 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.024 |
0.7 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |